These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27474881)

  • 1. Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.
    Li L; Piontek K; Ishida M; Fausther M; Dranoff JA; Fu R; Mezey E; Gould SJ; Fordjour FK; Meltzer SJ; Sirica AE; Selaru FM
    Hepatology; 2017 Feb; 65(2):501-514. PubMed ID: 27474881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
    Toshida K; Itoh S; Harada N; Morinaga A; Yugawa K; Tomiyama T; Kosai-Fujimoto Y; Tomino T; Kurihara T; Nagao Y; Morita K; Oda Y; Yoshizumi T
    Cancer Sci; 2023 Mar; 114(3):937-947. PubMed ID: 36369960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Cell-Derived Extracellular Vesicles Promote the Growth, Metastasis and Chemoresistance in Cholangiocarcinoma by Delivering microRNA-210 to Downregulate RECK.
    Fu Y; Liu Y; Liu K; Tan L
    Mol Biotechnol; 2023 Jul; 65(7):1151-1164. PubMed ID: 36454533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers.
    Xu Y; Leng K; Yao Y; Kang P; Liao G; Han Y; Shi G; Ji D; Huang P; Zheng W; Li Z; Li J; Huang L; Yu L; Zhou Y; Jiang X; Wang H; Li C; Su Z; Tai S; Zhong X; Wang Z; Cui Y
    Hepatology; 2021 Apr; 73(4):1419-1435. PubMed ID: 32750152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of microRNA-203 in cholangiocarcinoma.
    Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
    Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
    Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.
    Olaru AV; Ghiaur G; Yamanaka S; Luvsanjav D; An F; Popescu I; Alexandrescu S; Allen S; Pawlik TM; Torbenson M; Georgiades C; Roberts LR; Gores GJ; Ferguson-Smith A; Almeida MI; Calin GA; Mezey E; Selaru FM
    Hepatology; 2011 Dec; 54(6):2089-98. PubMed ID: 21809359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
    Utaijaratrasmi P; Vaeteewoottacharn K; Tsunematsu T; Jamjantra P; Wongkham S; Pairojkul C; Khuntikeo N; Ishimaru N; Sirivatanauksorn Y; Pongpaibul A; Thuwajit P; Thuwajit C; Kudo Y
    Mol Cancer; 2018 Jan; 17(1):10. PubMed ID: 29347950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
    Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
    Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
    Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
    Li W; Sun Z; Chen C; Wang L; Geng Z; Tao J
    Biomed Pharmacother; 2018 Apr; 100():257-266. PubMed ID: 29438839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis.
    Chen C; Yang D; Wang Q; Wang X
    Med Sci Monit; 2015 Nov; 21():3585-90. PubMed ID: 26586458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
    Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
    Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.
    Lozano E; Macias RIR; Monte MJ; Asensio M; Del Carmen S; Sanchez-Vicente L; Alonso-Peña M; Al-Abdulla R; Munoz-Garrido P; Satriano L; O'Rourke CJ; Banales JM; Avila MA; Martinez-Chantar ML; Andersen JB; Briz O; Marin JJG
    Hepatology; 2019 Oct; 70(4):1246-1261. PubMed ID: 30972782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
    Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.
    Canu V; Sacconi A; Lorenzon L; Biagioni F; Lo Sardo F; Diodoro MG; Muti P; Garofalo A; Strano S; D'Errico A; Grazi GL; Cioce M; Blandino G
    Oncotarget; 2017 May; 8(18):29540-29557. PubMed ID: 28199974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma.
    Palumbo T; Poultsides GA; Kouraklis G; Liakakos T; Drakaki A; Peros G; Hatziapostolou M; Iliopoulos D
    BMC Cancer; 2016 Jun; 16():353. PubMed ID: 27259577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.